PET/CT早期预测骨质疏松性转移性前列腺癌ADT后骨相关事件
本研究基于治疗前18F-FDG PET/CT影像,回顾性纳入两中心118例接受ADT的骨质疏松性转移性前列腺癌患者,构建SVM模型预测ADT后骨相关事件进展。原发灶PCa_TBRmax在进展组显著更高,联合模型(PCa_TBRmax+PSA)内部验证AUC达0.93,外部验证AUC为0.86。
要点
- 治疗前原发灶PCa_TBRmax越高,ADT后骨相关事件进展风险越大。
- 联合PCa_TBRmax与PSA的模型预测效能优于单一影像或临床指标。
- 该模型有助于骨质疏松性mPCa患者ADT前的早期风险分层。
关键影像表现/征象
- 原发灶靶本比PCa_TBRmax在骨相关事件进展组显著高于非进展组(p=0.036)。
诊断标准与关键数值
- SVM模型内部验证最高AUC为0.84。
- 联合模型(PCa_TBRmax+PSA)内部验证AUC为0.93,外部验证AUC为0.86。
临床应用与阅片要点
- 阅片时可关注原发灶18F-FDG摄取程度,测量PCa_TBRmax并写入报告。
- 结合PSA水平使用联合模型进行ADT后骨相关事件风险分层。
局限性
- 回顾性研究设计,外部验证样本量仅18例。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Androgen deprivation therapy (ADT) is the cornerstone of treatment for metastatic prostate cancer (mPCa), but it increases the risk of skeletal-related events(SREs), especially for patients with osteoporosis. This study aimed to develop a predictive model for post-ADT SREs progression based on pre-treatment 18F-FDG PET/CT imaging.
METHODS: A total of 118 mPCa patients with osteoporosis who underwent 18F-FDG PET/CT pre-ADT were retrospectively collected from two centers. A comparative analysis of clinical and radiological characteristics, both quantitative and qualitative, was conducted between patients with and without baseline SREs, which were defined as skeletal-related events documented pre-ADT and bone-targeting agents. Subsequently, logistic regression analysis was employed to identify clinical predictors distinguishing patients with SRE progression from those without. Support Vector Machine (SVM) model was then constructed to predict post-ADT SRE progression. Model performance was assessed using receiver operating characteristic (ROC) curves and decision curve analysis (DCA).
RESULTS: In Center 1, 100 patients were stratified into progression (n = 45) and non-progression (n = 55) groups for model training and internal validation. An external validation cohort (n = 18) was obtained from Center 2. The target-to-background ratio of the primary tumor (PCa_TBRmax) was significantly higher in the SRE progression group (p = 0.036). In internal validation, the SVM model achieved the highest AUC of 0.84, while the combined model (incorporating PCa_TBRmax and PSA) reached the AUC of 0.93. In external validation, the combined model achieved an AUC of 0.86.
CONCLUSIONS: The combined clinical-radiological model based on PET/CT demonstrated predictive ability for SRE progression following ADT, offering a valuable tool for early risk stratification and personalized treatment planning in mPCa patients with osteoporosis.
引用
- Zeng Y, Shen S, Ma H, et al. Early prediction via PET/CT for skeletal-related events in osteoporotic men with metastatic prostate cancer undergoing androgen deprivation therapy. Eur J Radiol. 2026. PMID: 41926878. doi:10.1016/j.ejrad.2026.112822
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。